| Hosford-Dunn et al.(12)
|
longitudinal |
- |
USA |
With RFHL |
VRA, “play audiometry” “Crib-0-Gram”. |
1 year, 2 or 3 years. Complete audiological follow-up at 3 years old |
| Tucker & Bhattacharya(13)
|
not declared |
To assess ARC for severe bilateral HL |
England |
With and without RFHL |
ARC |
7 to 9 months, 18 months and complete audiological follow-up at 3 years old |
| Fowler et al.(14)
|
coorte |
To predict whether the UNHS would identify SNHL caused by CMV |
USA |
CMV |
Frequency-specific ABR, behavioral audiometry, speech audiometry, immitanciometry |
3 to 8 weeks, 6 and 12 months and posteriorly, “annually” |
| Norton et al.(15)
|
prospective multicenter |
To determine the performance characteristics of TOAE, DPOAE ABR, at the corrected ages of 8 to 12 months |
USA |
With IRDA |
VRA |
8 to 12 months of corrected age |
| Norton et al.(16)
|
prospective multicenter |
To determine the accuracy of TOAE, DPOAE and ABR to predict behavioral hearing status at 8 to 12 months of corrected age |
USA |
With IRDA |
VRA |
8 to 12 months of corrected age |
| Ari-Even Roth et al.(17)
|
coorte |
To study the prevalence of HL in newborns with ELW at birth and evaluate the effectiveness of TOAE as a screening tool |
Israel |
Premature/low weight |
bone ABR and click ABR |
1 month after discharge and audiological follow-up in “regular periods” up to 3 years |
| Iwasakiet al.(18)
|
prospective |
To assess the audiological outcome of long-term follow-up of infants with asymptomatic CMV infection |
Japan |
CMV |
Frequency-specific ABR, behavioral audiometry |
Intervals from 6-12 months to 4 years |
| Barboza et al.(9)
|
descriptive retrospective |
To verify the occurrence of HL and its correlation with RFHL in babies from a UNHS service |
Brazil |
With RFHL |
ABR |
6 months |
| Wilson et al.(19)
|
retrospective |
To assess long-term audiological outcomes in a neonatal follow-up program |
Canada |
Congenital Diaphragmatic Hernia |
Standard audiometry according to the age, OAE, immitanciometry |
8, 18 months, 3 years |
| Beswick et al.(20)
|
retrospective |
To investigate the RFHL most likely to predict the occurrence of postnatal HL |
Australia |
With RFHL |
Otoscopy, tympanometry, ABR, VRA, DPOAE and TOAE, “play audiometry”. Tests chosen according to the age of the children. |
RFHL congenital infection: 3, 6 months and then every 6 months until 2 years, with discharge assessment within 3 years. RFHL family history: at 6 months and then every 6 months until 2 years, with discharge assessment at 3. Missing RFHL: single consultation from 9 to 12 months and then discharge assessment at 3.5 years old |
| Wood et al.(21)
|
retrospective |
To evaluate the UNHS performance in England |
England |
Newborns that passed the a-ABR but not in the TOAE |
- |
8 months |
| Karimian et al.(22)
|
prospective |
To assess the prevalence and the prognosis of the cCMV infection in Iran |
Iran |
CMV |
ABR |
ABR at 12 months. Regular visits at 2, 4, 6, 9 and 12 months |
| Yılmazer et al.(23)
|
not declared |
To present the results of the follow-up of NB after UNHS and determine the age of diagnosis, adaptation of hearing aids and cochlear implant in NB with HL |
Turkey |
With RFHL |
a-ABR |
1 week |
| Molini et al.(24)
|
retrospective |
To examine the results of the program and its evolution in the first 2.5 years of implementation |
Italy |
With RFHL |
- |
6 in 6 meses, up to 3 years |
| Sabbag & Lacerda(25)
|
observational, retrospective and quantitative |
To analyze the flow of the UNHS in FHS through tracking and monitoring of children |
Brazil |
With and without RFHL |
Interview |
0-1 year |
| Dumanch et al.(26)
|
retrospective |
To analyze the association between the RFHL and audiological status in early childhood and the follow-up rates of children approved or referred by RFHL |
USA |
With RFHL |
- |
3 years |
| Turchetta et al.(27)
|
retrospective |
To present and discuss the preliminary results of the UNHS program in the Lazio region |
Italy |
With RFHL |
TOAE, ABR, immitanciometry |
6 in 6 months for the first 3 years, then annually for the next 3 years |
| Foulon et al.(28)
|
prospective |
To determine the prevalence of HL in children with CMV. To analyze the possible determinants RFHL and to propose recommendations to NB screening and follow-up. |
Belgium |
CMV |
- |
Between 5 and 12 months, then annually until 4 years |
| Schaefer et al.(29)
|
not declared |
To investigate the feasibility to use the LittlEARS® Auditory Questionnaire (LEAQ®) as part of the newborn hearing screening program in Germany |
Germany |
With and without RFHL |
Questionnaires and specific exams according to the results |
3 years |
| McInerney et al.(30)
|
retrospective |
To assess the adherence of families to the recommendations for continuous monitoring of infants with RFHL |
USA |
With RFHL |
Otoscopy, tympanometry, behavioral audiometry, sound field audiometry, frequency-specific ABR, DPOAE. According to age |
3 and 6, then every 6 months until 24-30 months |
| Basonbul et al.(8)
|
retrospective |
To present auditory results for children with DS during the first 8 years of life and assess these results in the context of current screening guidelines. |
USA |
Down Sindrome |
ABR or behavioral audiometry. According to the child 's development |
6 in 6 months up to 3-4 years. Afterwards annually or when necessary |